ProteoNic Biosciences B.V.. (3/13/23). "Press Release: ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network". |
2024-03-13 |
Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. |
2024-03-13 |
Mahana Therapeutics Inc.. (3/12/24). "Press Release: Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions". San Francisco, CA. |
2024-03-12 |
Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
Praque.bio, z.s.. (3/11/24). "Press Release: This Fall Prague Will Be the Stage for a Showcase of Cutting-edge Biotechnologies Featuring Prominent Figures such as Christian A. Stein, Petr Jansa, and other Leading Experts". Prague. |
2024-03-11 |
NanoString Technologies, Inc.. (3/10/24). "Press Release: Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies". Seattle, WA. |
2024-03-10 |
IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried. |
2024-03-08 |
ProteinDistillery GmbH. (3/7/24). "Press Release: ProteinDistillery Raises €15 Million in Seed Funding". Esslingen & Berlin. |
2024-03-07 |
Invivo Partners. (3/5/24). "Press Release: Invivo Partners Is Preparing to Launch a €100M Invivo Ventures III Fund to Invest in Leading-edge Life Sciences". Barcelona. |
2024-03-05 |
C4 Therapeutics, Inc.. (3/4/24). "Press Release: C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins". Watertown, MA. |
2024-03-04 |
Precisio Biotix Therapeutics, Inc.. (3/1/24). "Press Release: Precisio Biotix Therapeutics Acquires London-headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists". Dover, DE. |
2024-03-01 |
Pierre Fabre. (3/1/24). "Press Release: Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories". San Francisco, CA & Castres. |
2024-03-01 |
BRAIN Biotech AG. (2/29/24). "Press Release: BRAIN Biotech AG Successfully Placed EUR 5.0 Million Convertible Bond for the Financing of Further Growth Initiatives [Not for US, AU, et al.]". Zwingenberg. |
2024-02-29 |
Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden. |
2024-02-29 |
Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". |
2024-02-29 |
Precirix N.V.. (2/29/24). "Press Release: Tom Plitz Commences Role as Chief Executive Officer of Precirix". Brussels. |
2024-02-29 |
Neobe Therapeutics Ltd.. (2/29/24). "Press Release: Neobe Therapeutics Raises over $2m for Synthetic Biology Enabled Tumour Microenvironment Remodelling". |
2024-02-29 |
Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
Viatris Inc.. (2/28/24). "Press Release: Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance". Pittsburgh, PA. |
2024-02-28 |
Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil. |
2024-02-28 |
Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. |
2024-02-28 |
Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
Luxembourg Institute of Health (LIH). (2/27/24). "Press Release: Strategic Partnership Forges Innovation in Luxembourg HealthTech. Luxembourg Institute of Health and Catalpa Ventures Join Forces". |
2024-02-27 |
Stilla Technologies S.A.S.. (2/22/24). "Press Release: Stilla Technologies Closes $26.5M Series C Financing to Accelerate Commercialization of Its Digital PCR Platform – Expands Leadership team". Paris & Boston, MA. |
2024-02-22 |
Ansa Biotechnologies, Inc.. (2/22/24). "Press Release: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences". Emeryville, CA. |
2024-02-22 |
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
Plasmion GmbH. (2/21/24). "Press Release: Plasmion and Waters Corporation Sign a Co-marketing and Co-promotion Agreement to Enhance and Simplify Chemical Analysis". Augsburg. |
2024-02-21 |
Cyclize GmbH. (2/21/24). "Press Release: ClimateTech Startup Cyclize Secures €5 Million in Seed Funding for Revolutionary Plastic Recycling Technology". Munich. |
2024-02-21 |
Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA. |
2024-02-21 |
Cresset Biomolecular Discovery Ltd.. (2/21/24). "Press Release: Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology". Cambridge. |
2024-02-21 |
Biotimus S.A.S.. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology". |
2024-02-20 |
Omnix Medical Ltd.. (2/20/24). "Press Release: Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6". Jerusalem. |
2024-02-20 |
Evonik. (2/20/24). "Press Release: Evonik Partners with the University of Mainz to Commercialize a New Class of PEG Lipids for Nucleic Acid Delivery". Essen. |
2024-02-20 |
AZMed S.A.S.. (2/20/24). "Press Release: AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI". Paris. |
2024-02-20 |
MIP Discovery Ltd.. (2/19/24). "Press Release: MIP Discovery Closes £7M Series A Financing to Drive Commercialization in Cell and Gene Therapy Space". |
2024-02-19 |
Freenome, Inc.. (2/15/24). "Press Release: Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection". South San Francisco, CA. |
2024-02-15 |
Firefly Bio, Inc.. (2/15/24). "Press Release: Firefly Bio Debuts with $94 Million Series A Financing". South San Francisco, CA. |
2024-02-15 |
SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin. |
2024-02-15 |
Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne. |
2024-02-14 |
Newcells Biotech Ltd.. (2/14/24). "Press Release: Biotech Raises further £2.35m for Lab Models that Help Avoid Animal Testing". |
2024-02-14 |
MTIP AG. (2/14/24). "Press Release: MTIP Invests $15 Million in Caresyntax". |
2024-02-14 |
CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA. |
2024-02-13 |
CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z |
2024-02-13 |
VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY. |
2024-02-13 |
PathAI Inc.. (2/13/24). "Press Release: PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics". Boston, MA. |
2024-02-13 |
Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London. |
2024-02-13 |
Scinai Immunotherapeutics Ltd.. (2/13/24). "Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales". Jerusalem. |
2024-02-13 |
Repare Therapeutics Inc.. (2/12/24). "Press Release: Repare Therapeutics to Regain Global Rights to Camonsertib". Cambridge, MA & Montréal. |
2024-02-12 |
Amply Discovery Ltd.. (2/12/24). "Press Release: Amply Discovery Raises £1.4m in Innovate UK Grant Funding to Tackle Complex Diseases". |
2024-02-12 |
T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer". |
2024-02-09 |
Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier. |
2024-02-09 |
BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London. |
2024-02-08 |
GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris. |
2024-02-08 |
Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". |
2024-02-08 |
Israel Advanced Technology Industries (IATI). (2/8/24). "Press Release: MIXiii Health-Tech.IL Annual Conference to Showcase Resilience and Growth of Israel's Life Sciences Industry Amid War". Herzliya. |
2024-02-08 |
VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. |
2024-02-07 |
FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
Sablebio Ltd. (Sable Bio). (2/6/24). "Press Release: Sable Bio Raises £1.5m Pre-seed Round to Transform Drug Discovery Safety Assessments". London. |
2024-02-06 |
Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. |
2024-02-05 |
MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. |
2024-02-05 |
NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. |
2024-02-02 |
Theryq. (2/2/24). "Press Release: Theryq and Gustave Roussy Have Been Selected as Part of the "i-Démo" France 2030 Call for Projects". Rousset. |
2024-02-02 |
ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. |
2024-02-01 |
Praque.bio, z.s.. (2/1/24). "Press Release: Petra Kinzlova Became the New Director of the Prague.bio Cluster". Prague. |
2024-02-01 |
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". |
2024-02-01 |
Silence Therapeutics plc. (1/31/24). "Press Release: Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference". London. |
2024-01-31 |
BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. |
2024-01-31 |
ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. |
2024-01-30 |
Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. |
2024-01-30 |
Aqemia S.A.S.. (1/30/24). "Press Release: Aqemia Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline". Paris. |
2024-01-30 |
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. |
2024-01-30 |
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
Green Elephant Biotech GmbH. (1/29/24). "Press Release (Blog Post): Product Launch. Green Elephant Biotech Launches the World's First Plant-based 96-well Plate". |
2024-01-29 |
Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". |
2024-01-29 |
Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. |
2024-01-29 |
Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. |
2024-01-29 |
Formycon AG. (1/29/24). "Press Release: Gedeon Richter Becomes Strategic Investor of Formycon via Equity Investment". Munich & Budapest. |
2024-01-29 |
SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". |
2024-01-26 |
SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". |
2024-01-26 |
Pierre Fabre. (1/26/24). "Press Release: Eau Thermale Avène Hits a Billion Euros in Turnover, and Strengthens Its Medical Positioning". Toulouse. |
2024-01-26 |
Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel. |
2024-01-25 |
Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. |
2024-01-25 |
InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. |
2024-01-25 |
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. |
2024-01-23 |
Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. |
2024-01-23 |
ReiThera S.r.l.. (1/22/24). "Press Release: ReiThera Srl, the Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation". Rome & Cambridge, MA. |
2024-01-22 |
BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. |
2024-01-22 |
Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg. |
2024-01-22 |
Sano Genetics Ltd.. (1/22/24). "Press Release: Sano Genetics Raises $11.4 Million Led by Plural to Power Precision Medicine Revolution with Seamless Trials". Cambridge. |
2024-01-22 |
Sensorion S.A.. (1/19/24). "Press Release: Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries". Montpellier. |
2024-01-19 |
CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. |
2024-01-17 |
ITM Isotope Technologies Munich SE. (1/16/24). "Press Release: ITM Appoints Dr. Mark Harfensteller as Member of Its Executive Board". Garching. |
2024-01-16 |
Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. |
2024-01-16 |
BIO Deutschland e. V.. (1/11/24). "Press Release: Biotech Industry. Financing Remains Stable – Turnaround on the Horizon". Berlin. |
2024-01-11 |
WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv. |
2024-01-11 |
Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres. |
2024-01-10 |
Roche Deutschland Holding GmbH. (1/10/24). "Press Release: Prof. Hagen Pfundner wird zum 1. Mai 2024 Vorsitzender der Roche Deutschland Holding GmbH". |
2024-01-10 |